Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • Singapore Stocks
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mirna Therapeutics

1.71
+0.02001.18%
Volume:40.94K
Turnover:70.00K
Market Cap:35.67M
PE:-1.35
High:1.75
Open:1.73
Low:1.65
Close:1.69
Loading ...
OverviewCompanyNewsFilings
Aug 28, 2018

Correspondence

Aug 23, 2018

Correspondence

Apr 12, 2018

Beneficial Ownership Change

Feb 14, 2018

Beneficial Ownership Change

Feb 01, 2018

Beneficial Ownership Change

SYNLOGIC公司。
Jan 26, 2018

Beneficial Ownership Change

SYNLOGIC公司。
Oct 23, 2017

Correspondence

Sep 26, 2017

Major Issues Report

SYNLOGIC公司。
Sep 07, 2017

Beneficial Ownership Change

SYNLOGIC公司。
Jul 11, 2017

Correspondence

Jun 09, 2017

Business Combinations

microrna的疗法,Inc .)
May 19, 2017

Business Combinations

microrna的疗法,Inc .)
May 17, 2017

Business Combinations

microrna的疗法,Inc .)
May 16, 2017

Beneficial Ownership Change

microrna的疗法,Inc .)
May 16, 2017

Business Combinations

microrna的疗法,Inc .)
Sep 30, 2015

[Amend]Public Prospectus

Sep 30, 2015

[Supp]Public Prospectus

Sep 30, 2015

[Amend]Public Prospectus

初始注册新的证券——修改
Sep 30, 2015

[Supp]Public Prospectus

自由写作招股说明书
Sep 29, 2015

[Amend]Public Prospectus

More

Analyst Rate

 
 
 
 

Corporate Actions

Split&Reverse Split
Aug 28, 2017 7 for 1
Symbol Change
Aug 28, 2017 SYBX
Financial Report Announcement
Aug 04, 2017
Financial Report Announcement
May 09, 2017
Financial Report Announcement
Nov 10, 2016

Dividend History

no data

No relevant data is available

Valuation Analysis

 
Current
 
Sector Average
 
Historical Percentile
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.